The study of sleep deprivation in huma
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000046232
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Not provided
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who live with their infants less than one year old 5. Subjects who co-sleep with their children (one to six years old) 6. Subjects whose sleeping time or habit is irregular due to working a late-night shift 7. Subjects who wake up for urination three times or more during nocturnal sleep 8. Subjects who have the opportunity to drive (passenger cars, motorcycles, buses, trains, airplanes, other vehicles that require a license, bicycles, and kick scooters) during the study 9. Subjects who may intensely exercise during the study 10. Subjects who take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily use 11. Subjects currently taking medicines (include herbal medicines) and supplements 12. Subjects who are allergic to medications 13. Subjects who are pregnant, breast-feeding, and planning to become pregnant 14. Subjects who suffer from COVID-19 15. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 16. Subjects who are judged as ineligible to participate in the study by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method